Ab initio calculation of the interaction energy in the P2 binding pocket of HIV-1 protease

被引:8
|
作者
Nivesanond, K
Peeters, A
Lamoen, D
Van Alsenoy, C
机构
[1] Univ Antwerp, Dept Chem, B-2610 Antwerp, Belgium
[2] Tibotec BVBA, B-2800 Mechelen, Belgium
[3] Univ Antwerp, Dept Phys, B-2020 Antwerp, Belgium
关键词
ab initio calculations; electrostatic potential map; HIV-1; protease; inhibitors; interaction energy; stockholder charges;
D O I
10.1002/qua.20724
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Interactions at the P2 binding pocket of human immunodeficiency virus type 1 (HIV-1) protease have been studied using calculated interaction energies for model systems that mimic this binding pocket. Models were built for the P2 pocket of HIV-1 protease in complex with TMC114, nelfinavir, and amprenavir. A two-step procedure was applied. In the first step, the size of the model system was confined to similar to 40 atoms, and the interaction energy was calculated at different computational levels. In the second step, the size of the system was increased to 138 atoms, and the calculations were only performed at the HF/6-31G** level. The interaction energy of the HIV-1 protease/TMC114 complex was found to be more favorable than the interaction energies of the other complexes because of the additional hydrogen bond interaction this inhibitor is able to make with the HIV-1 protease backbone. The results of the calculations are supported by stockholder charges and electrostatic potential maps. (c) 2005 Wiley Periodicals, Inc.
引用
收藏
页码:292 / 299
页数:8
相关论文
共 50 条
  • [1] Functionalized aliphatic P2/P2' analogs of HIV-1 protease inhibitor DMP323
    Smallheer, JM
    McHugh, RJ
    Chang, CH
    Kaltenbach, RF
    Worley, TV
    Klabe, RM
    Bacheler, LT
    Rayner, MM
    EricksonViitanen, S
    Seitz, SP
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (11) : 1365 - 1370
  • [2] The binding energy of HIV-1 protease inhibitor
    Ka, J
    Park, SH
    Kim, H
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 1996, 17 (01) : 19 - 24
  • [3] Cyclic sulfamide HIV-1 protease inhibitors, with sidechains spanning from P2/P2′ to P1/P1′
    Ax, A
    Schaal, W
    Vrang, L
    Samuelsson, B
    Hallberg, A
    Karlén, A
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (03) : 755 - 764
  • [4] Unsymmetrical cyclic ureas as HIV-1 protease inhibitors: Novel biaryl indazoles as P2/P2' substituents
    Patel, M
    Rodgers, JD
    McHugh, RJ
    Johnson, BL
    Cordova, BC
    Klabe, RM
    Bacheler, LT
    Erickson-Viitanen, S
    Ko, SS
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (22) : 3217 - 3220
  • [5] An ab initio quantum mechanical model for the catalytic mechanism of HIV-1 protease
    Lee, H
    Darden, TA
    Pedersen, LG
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1996, 118 (16) : 3946 - 3950
  • [6] Inhibitors of the C2-symmetric HIV-1 protease:: Nonsymmetric binding of a symmetric cyclic sulfamide with ketoxime groups in the P2/P2′ side chains
    Hultén, J
    Andersson, HO
    Schaal, W
    Danielson, HU
    Classon, B
    Kvarnström, I
    Karlén, A
    Unge, T
    Samuelsson, B
    Hallberg, A
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (20) : 4054 - 4061
  • [7] NOVEL INHIBITORS OF HIV-1 PROTEASE CONTAINING AN ISOPHTHALIC CARBOXAMIDE AT THE P2 SITE
    KALDOR, SW
    DRESSMAN, BA
    HAMMOND, M
    APPELT, K
    SU, KS
    CAMPANALE, KM
    BURGESS, JA
    LUBBENHUSEN, PP
    BAXTER, AJ
    MUESING, MA
    HATCH, SD
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 209 : 122 - MEDI
  • [8] Design and synthesis of HIV-1 protease inhibitors incorporating oxazolidinones as P2/P2' ligands in pseudosymmetric dipeptide isosteres
    Reddy, G. S. Kiran Kumar
    Ali, Akbar
    Nalam, Madhavi N. L.
    Anjum, Saima Ghafoor
    Cao, Hong
    Nathans, Robin S.
    Schiffer, Celia A.
    Rana, Tariq M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (18) : 4316 - 4328
  • [9] Design and synthesis of HIV-1 protease inhibitors.: Novel tetrahydrofuran P2/P2′-groups interacting with Asp29/30 of the HIV-1 protease.: Determination of binding from X-ray crystal structure of inhibitor protease complex
    Oscarsson, K
    Lahmann, M
    Lindberg, J
    Kangasmetsä, J
    Unge, T
    Oscarson, S
    Hallberg, A
    Samuelsson, B
    BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (06) : 1107 - 1115
  • [10] Novel spirocyclic pyrrolidones as P2/P1 mimetics in potent inhibitors of HIV-1 protease
    Kazmierski, WM
    Furfine, E
    Spaltenstein, A
    Wright, LL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (23) : 3431 - 3433